Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)
Clinical trial NCT04106349 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04106349
- Sponsor
- Ipsen
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-03
- Primary completion
- 2027-03-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.